Page 113 - Mercy MOR All Regions_FinalwVideo

Key Performance Indicators Metric $1,376 Springfield 2.0% % Variance 14.0% $24,669,484
Prior
Budget
Variance
Actual
($262,924)
$3,742,550
$3,902,246
-7.0%
Supply Expense
$4,005,474
Net Patient Revenue
-6.0%
$24,545,720
($1,574,915)
$26,120,635
15.8%
16.3%
14.3%
Supply Expense % Net Patient Revenue
Supply Expense per EIPA
$1,396
$1,425
1.4%
$20
1,397
128

1,525
Total Admissions
1,413
9.2%
15,847
17,071
7.7%

Total Patient Days
16,320
1,224
2,682
2,738
2,910
Total EIPAs
8.5%
228

IP Surgeries
15.5%
192
27
174
201

OP Surgeries
306

Total Surgeries
326
-6.1%
(20)
364
(40)
-26.3%
152

Outpatient Cath Lab Procedures 105 153 (48) -31.4% 172
112
96
Site Performance Summary
Springfield is over budget by $231K (6.2%). Primary contributing factors are: admissions up 9.2% and LOS up 9%; increased CRM
Volume in Surgery and the Cath lab accounted for $124K; drug spend associated with the Flu and Respiratory increased volume ($47K),
and lab increased spend on flu kits and Filmary (rapid respiratory and disease test). Total Supply cost associated with the flu volume
was an increase of $94K (Lab + $63K, IV + $15K, med/surg +$11K, EVS + $5K) versus prior year. Lower Cath Lab volume attributed to
the two highest volume Cardiologist being out at least a week each (Dr. Ahkter & Dr. Ashraf). While OR volume overall was down 6.1%
there Net Revenue was over budget by 7.1%
Key Challenges
Favorable to budget by $45K
Med/Surg Cath Lab under budget 27% $59K attributed to volume below budget, the two highest volume
Springfield Leader's Summary
Cardiologist (Dr. Ahkter [out 10 days], Dr. Ashraf )were each out for at least a week each.
OR under budget by 12%, $24K due to lower surgical volume -6%
Drugs over budget by $135K (13.5%)
Rx Tamiflu accounted for $9K, $25K in spend for COPD
$19K for Rituxamab which was not purchased in 2017 and an increase of $6K for stroke patient
drugs
Cath Lab implants were over budget by $155K. $88K in the Cath Lab for CRM and $36K in the OR
over budget for CRM. We implanted 3 additional pacers, 4 AICD and 4 BIV AICD.
Implants Implant other over budget $77K. Two additional AAA performed in the Cath Lab accounted for
$33K, and additional grafts performed in the Wound Clinics which is off set by revenue.
Lab over budget by $55K attributed to the flu and respiratory test supplies ($63K)
IV sets over by $23K due to flu $15K and B Braun IV catheters the were med surg supplies
before.
Other Expenses
Minor Equipment medical is over $27K, due to DME purchased of Cpap devices and ventilators.
These are rented to patients who then own them after a set period of time. Expenses hit when
purchased with revenue to follow over a 13 month period.
Actions Taken/Planned:
Met with COO, CFO and OR director and have put in place a process that will not allow a case to
be scheduled with high implant cost with out the director's and COO's approval.
Reviewed payment for Reveal LINQ. And reimbursement is good. There are a few inpatients and
I am working to verify the payment covers all charges.
Met with director of the wound clinics to verify that reimbursement is there for the graft cases.
There are a few that did not meet the criteria, but were approved based upon patient needs
and payer.